Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,328,911 papers from all fields of science
Search
Sign In
Create Free Account
Basal-Like Breast Carcinoma
Known as:
Basal-Like Breast Cancer
, Basal-Like Subtype of Breast Carcinoma
A biologic subset of breast carcinoma defined by high expression of genes characteristic of basal epithelial cells, including KRT5 and KRT17, annexin…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Breast
EGFR Protein Overexpression
EGFR gene
Epithelial Cells
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The Research Progress of Basal-like Breast Carcinoma
J. Zhang
,
D. Zhang
Cancer Genetics and Epigenetics
2018
Corpus ID: 86595056
Basal-like breast carcinoma is a heterogeneous disease of high malignancy and poor prognosis, which is subordinate to breast…
Expand
2018
2018
Abstract P2-09-32: Ki-67 index value and progesterone receptor status predict prognosis and suitable treatment in node-negative breast cancer patients with estrogen receptor positive and HER2…
N. Arima
,
R. Nishimura
,
+4 authors
Y. Toyozumi
2018
Corpus ID: 80407277
Background: Breast cancer is no longer a single disease with high molecular heterogeneity. Gene profiling has identified at least…
Expand
2016
2016
CRP 2 , a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis
X. Mao
,
M. Dieterle
,
+8 authors
Thomas
2016
Corpus ID: 73530834
A critical process underlying cancer metastasis is the acquisition by tumor cells of an invasive phenotype. At the subcellular…
Expand
2016
2016
Tumor Profiling: Adding Proteomics to Genomics.
Cancer Discovery
2016
Corpus ID: 19636777
Researchers have used mass spectrometry to conduct proteomic analyses of 77 genomically characterized breast tumors. Through this…
Expand
2015
2015
Forkhead box C 1 promoter upstream transcript , a novel long non-coding RNA , regulates proliferation and migration in basal-like breast cancer
Juntao Liu
,
Lei Shen
,
+4 authors
Peiliang Geng
2015
Corpus ID: 15580406
Recent studies have shown that long non-coding RNAs (lncRNAs) have crucial regulating roles in carcinogenesis. Forkhead box C1…
Expand
2013
2013
A germline mosaic BRCA 1 exon deletion in a woman with bilateral basal-like breast cancer
2013
Corpus ID: 45354648
To the Editor : Germline mutations in the BRCA1 and BRCA2 genes account for around half of all hereditary breast cancer cases and…
Expand
2012
2012
Abstract P3-06-03: Association between PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients
C. Jørgensen
,
T. Nielsen
,
+5 authors
B. Ejlertsen
2012
Corpus ID: 74785823
Background: Breast cancer can be subclassified into luminal A and B, basal-like and HER2-enriched subtypes, each with distinct…
Expand
2012
2012
A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results
J. Albanell
2012
Corpus ID: 78642879
Chemotherapy remains as the only systemic treatment option available for basal-like breast cancer (BC) patients. Preclinical…
Expand
2011
2011
Molecular and Cellular Pathobiology Engagement of I-Branching b-1 , 6N-Acetylglucosaminyltransferase 2 in Breast Cancer Metastasis and TGF-b Signaling
Haijun Zhang
,
F. Meng
,
+5 authors
Guojun Wu
2011
Corpus ID: 44773874
In this study, we have showed that GCNT2, a gene-encoding glucosaminyl (N-acetyl) transferase 2, I-branching enzyme, is…
Expand
2010
2010
Clinically relevant gene signatures in triple-negative and basal-like breast cancer.
A. Rody
,
T. Karn
,
+7 authors
M. Kaufmann
2010
Corpus ID: 74095709
521 Background: The relationship of triple-negative breast cancers (TNBC) to basal-like breast cancer (BLBC) is not fully clear…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE